Literature DB >> 33981467

International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Africa.

Fidelis Oguejiofor1, Daniel S Kiggundu2,3, Aminu K Bello4, Charles R Swanepoel5, Gloria Ashuntantang6, Vivekanand Jha7,8,9, David C H Harris10, Adeera Levin3, Marcello Tonelli11,12, Abdou Niang13, Nicola Wearne5,14, Mothusi Walter Moloi15, Ifeoma Ulasi16,17,18,19, Fatiu A Arogundade20, Syed Saad21, Deenaz Zaidi21, Mohamed A Osman22, Feng Ye21, Meaghan Lunney23, Timothy O Olanrewaju24, Udeme Ekrikpo25, Theophilus I Umeizudike26, Aliyu Abdu27, Aisha M Nalado27, Muhammad Aliyu Makusidi28, Hamidu M Liman29, Aminu Sakajiki29, Hassane M Diongole30,31, Maryam Khan32, Mohammed Benghanem Gharbi33, David W Johnson34,35,36, Ikechi G Okpechi5,14,21.   

Abstract

Despite positive economic forecasts, stable democracies, and reduced regional conflicts since the turn of the century, Africa continues to be afflicted by poverty, poor infrastructure, and a massive burden of communicable diseases such as HIV, malaria, tuberculosis, and diarrheal illnesses. With the rising prevalence of chronic kidney disease and kidney failure worldwide, these factors continue to hinder the ability to provide kidney care for millions of people on the continent. The International Society of Nephrology Global Kidney Health Atlas project was established to assess the global burden of kidney disease and measure global capacity for kidney replacement therapy (dialysis and kidney transplantation). The aim of this second iteration of the International Society of Nephrology Global Kidney Health Atlas was to evaluate the availability, accessibility, affordability, and quality of kidney care worldwide. We identified several gaps regarding kidney care in Africa, chief of which are (i) severe workforce limitations, especially in terms of the number of nephrologists; (ii) low government funding for kidney care; (iii) limited availability, accessibility, reporting, and quality of provided kidney replacement therapy; and (iv) weak national strategies and advocacy for kidney disease. We also identified that within Africa, the availability and accessibility to kidney replacement therapy vary significantly, with North African countries faring far better than sub-Sahara African countries. The evidence suggests an urgent need to increase the workforce and government funding for kidney care, collect adequate information on the burden of kidney disease from African countries, and develop and implement strategies to enhance disease prevention and control across the continent.
© 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  chronic kidney disease; dialysis; funding; kidney failure; kidney registries; workforce

Year:  2021        PMID: 33981467      PMCID: PMC8084720          DOI: 10.1016/j.kisu.2021.01.009

Source DB:  PubMed          Journal:  Kidney Int Suppl (2011)        ISSN: 2157-1716


  4 in total

1.  Global Dialysis Perspective: Ethiopia.

Authors:  Yewondwossen T Mengistu; Addisu M Ejigu
Journal:  Kidney360       Date:  2022-05-24

2.  High Prevalence of Chronic Kidney Disease Among People Living with Hypertension in Rural Sierra Leone: A Cross-Sectional Study.

Authors:  Chiyembekezo Kachimanga; Anu Jegede Williams; Musa Bangura; Marta Lado; Sahr Kanawa; Daniel Lavallie; Michael Mhango; Haja Isatta Wurie; Marta Patiño Rodriguez
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-12-21

3.  Challenges in Diagnosis and Management of Glomerular Disease in Resource-Limited Settings.

Authors:  Raja Ramachandran; Shabna Sulaiman; Prabhat Chauhan; Ifeoma Ulasi; Ugochi Onu; Russell Villaneuva; Muhammad Rafiqul Alam; Fazal Akhtar; Lloyd Vincent; Gurmehar S Aulakh; Aida Lydia Sutranto; Elena Zakharova; Vivekanand Jha
Journal:  Kidney Int Rep       Date:  2022-07-16

Review 4.  Paediatric Nephrology in Africa.

Authors:  Christopher I Esezobor; Adebimpe E Alakaloko; Bashir Admani; Rashid Ellidir; Peter Nourse; Mignon I McCulloch
Journal:  Curr Pediatr Rep       Date:  2021-10-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.